nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—ABCC2—bile duct—gallbladder cancer	0.0363	0.143	CbGeAlD
Arsenic trioxide—ABCC2—bile—gallbladder cancer	0.0279	0.11	CbGeAlD
Arsenic trioxide—CCND1—epithelium—gallbladder cancer	0.012	0.0475	CbGeAlD
Arsenic trioxide—CCND1—pancreas—gallbladder cancer	0.0107	0.0423	CbGeAlD
Arsenic trioxide—MAPK1—epithelium—gallbladder cancer	0.0101	0.04	CbGeAlD
Arsenic trioxide—TXNRD1—epithelium—gallbladder cancer	0.00943	0.0372	CbGeAlD
Arsenic trioxide—MAPK1—pancreas—gallbladder cancer	0.00902	0.0356	CbGeAlD
Arsenic trioxide—MAPK3—epithelium—gallbladder cancer	0.00897	0.0354	CbGeAlD
Arsenic trioxide—AKT1—epithelium—gallbladder cancer	0.00846	0.0334	CbGeAlD
Arsenic trioxide—TXNRD1—pancreas—gallbladder cancer	0.0084	0.0332	CbGeAlD
Arsenic trioxide—MAPK3—pancreas—gallbladder cancer	0.00799	0.0315	CbGeAlD
Arsenic trioxide—AKT1—pancreas—gallbladder cancer	0.00753	0.0297	CbGeAlD
Arsenic trioxide—JUN—epithelium—gallbladder cancer	0.00736	0.029	CbGeAlD
Arsenic trioxide—CCND1—liver—gallbladder cancer	0.00681	0.0269	CbGeAlD
Arsenic trioxide—JUN—pancreas—gallbladder cancer	0.00656	0.0259	CbGeAlD
Arsenic trioxide—MAPK1—liver—gallbladder cancer	0.00574	0.0227	CbGeAlD
Arsenic trioxide—TXNRD1—liver—gallbladder cancer	0.00534	0.0211	CbGeAlD
Arsenic trioxide—CCND1—lymph node—gallbladder cancer	0.00522	0.0206	CbGeAlD
Arsenic trioxide—MAPK3—liver—gallbladder cancer	0.00508	0.0201	CbGeAlD
Arsenic trioxide—AKT1—liver—gallbladder cancer	0.00479	0.0189	CbGeAlD
Arsenic trioxide—MAPK1—lymph node—gallbladder cancer	0.0044	0.0174	CbGeAlD
Arsenic trioxide—JUN—liver—gallbladder cancer	0.00417	0.0165	CbGeAlD
Arsenic trioxide—IKBKB—liver—gallbladder cancer	0.00415	0.0164	CbGeAlD
Arsenic trioxide—TXNRD1—lymph node—gallbladder cancer	0.0041	0.0162	CbGeAlD
Arsenic trioxide—MAPK3—lymph node—gallbladder cancer	0.0039	0.0154	CbGeAlD
Arsenic trioxide—AKT1—lymph node—gallbladder cancer	0.00367	0.0145	CbGeAlD
Arsenic trioxide—JUN—lymph node—gallbladder cancer	0.0032	0.0126	CbGeAlD
Arsenic trioxide—IKBKB—lymph node—gallbladder cancer	0.00318	0.0126	CbGeAlD
Arsenic trioxide—CYP1A1—epithelium—gallbladder cancer	0.00277	0.0109	CbGeAlD
Arsenic trioxide—ABCC2—liver—gallbladder cancer	0.00227	0.00896	CbGeAlD
Arsenic trioxide—CYP1B1—liver—gallbladder cancer	0.00222	0.00878	CbGeAlD
Arsenic trioxide—ABCC2—lymph node—gallbladder cancer	0.00174	0.00687	CbGeAlD
Arsenic trioxide—CYP1B1—lymph node—gallbladder cancer	0.0017	0.00673	CbGeAlD
Arsenic trioxide—CYP1A1—liver—gallbladder cancer	0.00157	0.0062	CbGeAlD
Arsenic trioxide—ABCB1—epithelium—gallbladder cancer	0.00144	0.00569	CbGeAlD
Arsenic trioxide—ABCB1—pancreas—gallbladder cancer	0.00128	0.00506	CbGeAlD
Arsenic trioxide—CYP1A1—lymph node—gallbladder cancer	0.00121	0.00476	CbGeAlD
Arsenic trioxide—CYP3A4—liver—gallbladder cancer	0.00115	0.00455	CbGeAlD
Arsenic trioxide—ABCB1—liver—gallbladder cancer	0.000817	0.00322	CbGeAlD
Arsenic trioxide—ABCB1—lymph node—gallbladder cancer	0.000626	0.00247	CbGeAlD
Arsenic trioxide—CCND1—Cell Cycle—TP53—gallbladder cancer	0.000163	0.000218	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular Senescence—TP53—gallbladder cancer	0.000163	0.000218	CbGpPWpGaD
Arsenic trioxide—AKT1—B Cell Activation—HRAS—gallbladder cancer	0.000163	0.000218	CbGpPWpGaD
Arsenic trioxide—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.000163	0.000218	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000162	0.000217	CbGpPWpGaD
Arsenic trioxide—MAPK1—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000162	0.000217	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—HRAS—gallbladder cancer	0.000162	0.000217	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.000162	0.000216	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR—HRAS—gallbladder cancer	0.000161	0.000215	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—ERBB3—gallbladder cancer	0.000161	0.000215	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00016	0.000214	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000159	0.000214	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—NRAS—gallbladder cancer	0.000159	0.000213	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by PDGF—HRAS—gallbladder cancer	0.000159	0.000213	CbGpPWpGaD
Arsenic trioxide—AKT1—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000156	0.000209	CbGpPWpGaD
Arsenic trioxide—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000155	0.000208	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.000154	0.000206	CbGpPWpGaD
Arsenic trioxide—MAPK1—Focal Adhesion—HRAS—gallbladder cancer	0.000153	0.000205	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—NRAS—gallbladder cancer	0.000151	0.000202	CbGpPWpGaD
Arsenic trioxide—MAPK3—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000151	0.000202	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—EGFR—gallbladder cancer	0.000149	0.0002	CbGpPWpGaD
Arsenic trioxide—MAPK1—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000147	0.000197	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.000147	0.000197	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.000146	0.000196	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—EGFR—gallbladder cancer	0.000145	0.000194	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—NRAS—gallbladder cancer	0.000145	0.000194	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000144	0.000193	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—NRAS—gallbladder cancer	0.000144	0.000193	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Activation—HRAS—gallbladder cancer	0.000144	0.000192	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—KRAS—gallbladder cancer	0.000141	0.000189	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000139	0.000186	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—ERBB2—gallbladder cancer	0.000139	0.000186	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—TP53—gallbladder cancer	0.000139	0.000186	CbGpPWpGaD
Arsenic trioxide—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.000139	0.000186	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—EGFR—gallbladder cancer	0.000138	0.000184	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—ERBB4—gallbladder cancer	0.000137	0.000184	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—NRAS—gallbladder cancer	0.000137	0.000183	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—KRAS—gallbladder cancer	0.000137	0.000183	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—ERBB2—gallbladder cancer	0.000135	0.000181	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000132	0.000177	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—ERBB4—gallbladder cancer	0.000132	0.000177	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—EGFR—gallbladder cancer	0.000132	0.000176	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—BCL2—gallbladder cancer	0.000132	0.000176	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—EGFR—gallbladder cancer	0.000131	0.000175	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—KRAS—gallbladder cancer	0.00013	0.000174	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—TP53—gallbladder cancer	0.00013	0.000174	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—ERBB2—gallbladder cancer	0.000128	0.000172	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ERBB4—gallbladder cancer	0.000128	0.000171	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—ERBB2—gallbladder cancer	0.000128	0.000171	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000127	0.00017	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—BCL2—gallbladder cancer	0.000126	0.000169	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000125	0.000168	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—EGFR—gallbladder cancer	0.000125	0.000167	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—KRAS—gallbladder cancer	0.000124	0.000167	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—KRAS—gallbladder cancer	0.000124	0.000166	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—TP53—gallbladder cancer	0.000123	0.000165	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—ERBB2—gallbladder cancer	0.000123	0.000164	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—BCL2—gallbladder cancer	0.000123	0.000164	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ERBB4—gallbladder cancer	0.000122	0.000163	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ERBB4—gallbladder cancer	0.000122	0.000163	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000122	0.000163	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—HRAS—gallbladder cancer	0.00012	0.00016	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—ERBB2—gallbladder cancer	0.000119	0.00016	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—ERBB3—gallbladder cancer	0.000119	0.000159	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000118	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ERBB4—gallbladder cancer	0.000118	0.000158	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—ERBB2—gallbladder cancer	0.000118	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—KRAS—gallbladder cancer	0.000118	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—BCL2—gallbladder cancer	0.000117	0.000156	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ERBB4—gallbladder cancer	0.000116	0.000156	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—HRAS—gallbladder cancer	0.000116	0.000156	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—ERBB3—gallbladder cancer	0.000114	0.000153	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—ERBB2—gallbladder cancer	0.000113	0.000152	CbGpPWpGaD
Arsenic trioxide—MAPK1—Neuronal System—HRAS—gallbladder cancer	0.000113	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000112	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ERBB4—gallbladder cancer	0.000112	0.000151	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—BCL2—gallbladder cancer	0.000112	0.000149	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ERBB3—gallbladder cancer	0.000111	0.000148	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—HRAS—gallbladder cancer	0.000111	0.000148	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—ERBB2—gallbladder cancer	0.000108	0.000145	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000108	0.000144	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—HRAS—gallbladder cancer	0.000106	0.000142	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—NRAS—gallbladder cancer	0.000106	0.000142	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ERBB3—gallbladder cancer	0.000105	0.000141	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ERBB3—gallbladder cancer	0.000105	0.000141	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—HRAS—gallbladder cancer	0.000105	0.000141	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—ERBB2—gallbladder cancer	0.000104	0.000139	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—NRAS—gallbladder cancer	0.000104	0.000139	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—NRAS—gallbladder cancer	0.000103	0.000137	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ERBB3—gallbladder cancer	0.000102	0.000137	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ERBB3—gallbladder cancer	0.000101	0.000135	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—ERBB2—gallbladder cancer	0.000101	0.000135	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—NRAS—gallbladder cancer	0.000101	0.000135	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—HRAS—gallbladder cancer	0.0001	0.000134	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—NRAS—gallbladder cancer	9.76e-05	0.000131	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—NRAS—gallbladder cancer	9.72e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ERBB3—gallbladder cancer	9.72e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—EGFR—gallbladder cancer	9.64e-05	0.000129	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—NRAS—gallbladder cancer	9.58e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—EGFR—gallbladder cancer	9.35e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—NRAS—gallbladder cancer	9.34e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—KRAS—gallbladder cancer	9.1e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—NRAS—gallbladder cancer	9.06e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—NRAS—gallbladder cancer	8.97e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—KRAS—gallbladder cancer	8.93e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—EGFR—gallbladder cancer	8.89e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB4—gallbladder cancer	8.88e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—EGFR—gallbladder cancer	8.86e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—KRAS—gallbladder cancer	8.83e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—KRAS—gallbladder cancer	8.66e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—NRAS—gallbladder cancer	8.62e-05	0.000115	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB4—gallbladder cancer	8.53e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—EGFR—gallbladder cancer	8.51e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	8.43e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—KRAS—gallbladder cancer	8.4e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—KRAS—gallbladder cancer	8.37e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB4—gallbladder cancer	8.27e-05	0.000111	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—EGFR—gallbladder cancer	8.25e-05	0.000111	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—NRAS—gallbladder cancer	8.25e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—KRAS—gallbladder cancer	8.24e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—EGFR—gallbladder cancer	8.17e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—KRAS—gallbladder cancer	8.04e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	7.96e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TP53—gallbladder cancer	7.94e-05	0.000106	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—NRAS—gallbladder cancer	7.92e-05	0.000106	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB4—gallbladder cancer	7.87e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EGFR—gallbladder cancer	7.85e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—KRAS—gallbladder cancer	7.8e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—HRAS—gallbladder cancer	7.74e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—KRAS—gallbladder cancer	7.72e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TP53—gallbladder cancer	7.7e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB3—gallbladder cancer	7.68e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—BCL2—gallbladder cancer	7.66e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—NRAS—gallbladder cancer	7.66e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—HRAS—gallbladder cancer	7.59e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB4—gallbladder cancer	7.53e-05	0.000101	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EGFR—gallbladder cancer	7.51e-05	0.000101	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—HRAS—gallbladder cancer	7.51e-05	0.000101	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—ERBB2—gallbladder cancer	7.44e-05	9.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—KRAS—gallbladder cancer	7.42e-05	9.94e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB3—gallbladder cancer	7.37e-05	9.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—HRAS—gallbladder cancer	7.36e-05	9.86e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—BCL2—gallbladder cancer	7.36e-05	9.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TP53—gallbladder cancer	7.33e-05	9.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—TP53—gallbladder cancer	7.27e-05	9.73e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—EGFR—gallbladder cancer	7.22e-05	9.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB3—gallbladder cancer	7.15e-05	9.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—ERBB2—gallbladder cancer	7.15e-05	9.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—HRAS—gallbladder cancer	7.14e-05	9.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—BCL2—gallbladder cancer	7.14e-05	9.56e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—HRAS—gallbladder cancer	7.11e-05	9.53e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—KRAS—gallbladder cancer	7.1e-05	9.51e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	7.08e-05	9.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—HRAS—gallbladder cancer	7.01e-05	9.38e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EGFR—gallbladder cancer	6.98e-05	9.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ERBB2—gallbladder cancer	6.94e-05	9.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—gallbladder cancer	6.91e-05	9.26e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—HRAS—gallbladder cancer	6.83e-05	9.15e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—KRAS—gallbladder cancer	6.82e-05	9.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB3—gallbladder cancer	6.81e-05	9.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—BCL2—gallbladder cancer	6.79e-05	9.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—HRAS—gallbladder cancer	6.63e-05	8.88e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ERBB2—gallbladder cancer	6.6e-05	8.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ERBB2—gallbladder cancer	6.6e-05	8.84e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—KRAS—gallbladder cancer	6.59e-05	8.83e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HRAS—gallbladder cancer	6.56e-05	8.79e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB3—gallbladder cancer	6.51e-05	8.72e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—BCL2—gallbladder cancer	6.5e-05	8.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ERBB2—gallbladder cancer	6.4e-05	8.58e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ERBB2—gallbladder cancer	6.31e-05	8.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—HRAS—gallbladder cancer	6.31e-05	8.45e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ERBB2—gallbladder cancer	6.09e-05	8.16e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—HRAS—gallbladder cancer	6.03e-05	8.08e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—NRAS—gallbladder cancer	5.95e-05	7.98e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—gallbladder cancer	5.86e-05	7.85e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HRAS—gallbladder cancer	5.79e-05	7.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—NRAS—gallbladder cancer	5.78e-05	7.74e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—NRAS—gallbladder cancer	5.66e-05	7.58e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—HRAS—gallbladder cancer	5.6e-05	7.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—NRAS—gallbladder cancer	5.5e-05	7.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—NRAS—gallbladder cancer	5.44e-05	7.29e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EGFR—gallbladder cancer	5.43e-05	7.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—NRAS—gallbladder cancer	5.28e-05	7.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EGFR—gallbladder cancer	5.26e-05	7.05e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EGFR—gallbladder cancer	5.16e-05	6.91e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—KRAS—gallbladder cancer	5.13e-05	6.86e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NRAS—gallbladder cancer	5.02e-05	6.73e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—NRAS—gallbladder cancer	5.02e-05	6.73e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EGFR—gallbladder cancer	5.01e-05	6.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—KRAS—gallbladder cancer	4.97e-05	6.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EGFR—gallbladder cancer	4.96e-05	6.64e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—KRAS—gallbladder cancer	4.87e-05	6.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NRAS—gallbladder cancer	4.87e-05	6.53e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB2—gallbladder cancer	4.81e-05	6.45e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EGFR—gallbladder cancer	4.81e-05	6.44e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—NRAS—gallbladder cancer	4.8e-05	6.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—KRAS—gallbladder cancer	4.73e-05	6.33e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—KRAS—gallbladder cancer	4.68e-05	6.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NRAS—gallbladder cancer	4.64e-05	6.21e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB2—gallbladder cancer	4.62e-05	6.19e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EGFR—gallbladder cancer	4.58e-05	6.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EGFR—gallbladder cancer	4.57e-05	6.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—KRAS—gallbladder cancer	4.54e-05	6.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB2—gallbladder cancer	4.48e-05	6.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—gallbladder cancer	4.44e-05	5.95e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—gallbladder cancer	4.38e-05	5.86e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—HRAS—gallbladder cancer	4.36e-05	5.83e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—KRAS—gallbladder cancer	4.32e-05	5.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—KRAS—gallbladder cancer	4.32e-05	5.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB2—gallbladder cancer	4.27e-05	5.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—HRAS—gallbladder cancer	4.23e-05	5.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—gallbladder cancer	4.22e-05	5.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—KRAS—gallbladder cancer	4.19e-05	5.62e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HRAS—gallbladder cancer	4.14e-05	5.55e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—KRAS—gallbladder cancer	4.13e-05	5.54e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB2—gallbladder cancer	4.08e-05	5.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—HRAS—gallbladder cancer	4.02e-05	5.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—KRAS—gallbladder cancer	3.99e-05	5.34e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HRAS—gallbladder cancer	3.98e-05	5.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HRAS—gallbladder cancer	3.86e-05	5.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HRAS—gallbladder cancer	3.67e-05	4.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HRAS—gallbladder cancer	3.67e-05	4.92e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NRAS—gallbladder cancer	3.66e-05	4.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HRAS—gallbladder cancer	3.56e-05	4.77e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NRAS—gallbladder cancer	3.52e-05	4.71e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HRAS—gallbladder cancer	3.51e-05	4.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NRAS—gallbladder cancer	3.41e-05	4.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HRAS—gallbladder cancer	3.39e-05	4.54e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—gallbladder cancer	3.34e-05	4.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NRAS—gallbladder cancer	3.25e-05	4.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—gallbladder cancer	3.2e-05	4.29e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KRAS—gallbladder cancer	3.15e-05	4.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—gallbladder cancer	3.11e-05	4.16e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NRAS—gallbladder cancer	3.11e-05	4.16e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KRAS—gallbladder cancer	3.03e-05	4.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—gallbladder cancer	2.96e-05	3.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KRAS—gallbladder cancer	2.94e-05	3.93e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—gallbladder cancer	2.83e-05	3.79e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—gallbladder cancer	2.8e-05	3.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KRAS—gallbladder cancer	2.79e-05	3.74e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—gallbladder cancer	2.69e-05	3.6e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HRAS—gallbladder cancer	2.68e-05	3.59e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KRAS—gallbladder cancer	2.67e-05	3.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—gallbladder cancer	2.61e-05	3.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HRAS—gallbladder cancer	2.57e-05	3.45e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HRAS—gallbladder cancer	2.5e-05	3.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—gallbladder cancer	2.48e-05	3.33e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—gallbladder cancer	2.38e-05	3.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HRAS—gallbladder cancer	2.37e-05	3.18e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HRAS—gallbladder cancer	2.27e-05	3.04e-05	CbGpPWpGaD
